HLA-C and neoplasm: Similar to studies that demonstrated an association between loss-of-HLA-heterozygosity with multiple tumor types and failure of therapeutic checkpoint blockade (28), this skewing away from equal biallelic HLA expression could represent an immunological escape mechanism that functions to reduce the diversity of possible tumor peptide-antigens displayed by MHC molecules.